Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamstersResearch in context

Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamstersResearch in context

Summary: Background: Convalescent plasma (CP) transfusion is an early option for treating infections with pandemic potential, often preceding vaccine or antiviral drug rollout. Heterogenous findings from randomized clinical trials on transfusion of COVID-19 CP (CCP) have been reported. However, met...

Full description

Bibliographic Details
Main Authors: Elise Wouters, Caro Verbrugghe, Rana Abdelnabi, Rosalie Devloo, Dorien De Clippel, Dirk Jochmans, Dominique De Bleser, Birgit Weynand, Veerle Compernolle, Johan Neyts, Hendrik B. Feys
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:EBioMedicine
Subjects:
COVID-19
SARS-CoV-2
Convalescent plasma
Prophylaxis
Intranasal
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396423001627

Internet

http://www.sciencedirect.com/science/article/pii/S2352396423001627

Similar Items